Covered recipient · General Payments record
JENNA E FLUEGGE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,360.39
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $570.23 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $255.15 | 12 |
| Novo Nordisk AS | $67.57 | 4 |
| PFIZER INC. | $51.98 | 3 |
| Astellas Pharma US Inc | $45.45 | 2 |
| GlaxoSmithKline, LLC. | $37.45 | 2 |
| Lilly USA, LLC | $35.61 | 2 |
| Exact Sciences Corporation | $25.48 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $20.18 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.12 | 1 |
| Amgen Inc. | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.70 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739031 | CMS |
| ABBVIE INC. | $34.60 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739033 | CMS |
| ABBVIE INC. | $26.12 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739035 | CMS |
| ABBVIE INC. | $15.73 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739037 | CMS |
| ABBVIE INC. | $30.37 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739039 | CMS |
| ABBVIE INC. | $12.33 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739041 | CMS |
| ABBVIE INC. | $22.28 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739043 | CMS |
| ABBVIE INC. | $21.94 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739045 | CMS |
| ABBVIE INC. | $21.61 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739047 | CMS |
| ABBVIE INC. | $16.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739049 | CMS |
| ABBVIE INC. | $13.70 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739051 | CMS |
| ABBVIE INC. | $16.76 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103739053 | CMS |
| Amgen Inc. | $15.24 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117252242 | CMS |
| Astellas Pharma US Inc | $24.08 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139280376 | CMS |
| Astellas Pharma US Inc | $21.37 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139382720 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.12 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118000815 | CMS |
| Exact Sciences Corporation | $25.48 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114659714 | CMS |
| GlaxoSmithKline, LLC. | $19.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116603692 | CMS |
| GlaxoSmithKline, LLC. | $17.66 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116409747 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $20.18 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146765432 | CMS |
| Lilly USA, LLC | $21.62 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135056906 | CMS |
| Lilly USA, LLC | $13.99 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135040201 | CMS |
| Novo Nordisk Inc | $15.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902979 | CMS |
| Novo Nordisk Inc | $18.27 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096566828 | CMS |
| Novo Nordisk Inc | $16.69 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896113 | CMS |
| Novo Nordisk Inc | $17.39 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096677349 | CMS |
| PFIZER INC. | $15.54 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131242715 | CMS |
| PFIZER INC. | $16.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131474934 | CMS |
| PFIZER INC. | $19.80 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131740558 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.